Mehran Rahimlou - Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Maryam Asadi - Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Nasrin Banaie - Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences,Ahvaz, Iran

Background and Aim: Several randomized clinical trials (RCTs) have investigated the effect of Alpha - Lipoic Acid (ALA) supplementation on cardio-metabolic parameters. However, the results were conflicting. Therefore, a meta-analysis, including randomized controlled trials (RCTs), was performed to assess the effect of ALA on some cardio metabolic parameters in adults with cardiovascular risk factors.Methods: A comprehensive, systematic literature search was done up to May 2018. From the eligible trials, 41 articles were selected for the meta-analysis. Two reviewers independently assessed the risk of bias and extracted data from included studies. Meta-analyses using random-effects model were used to analyze the dataResults: The result showed significant effect of ALA on FBS (WMD = - 6.57, 95% CI: -11.91 to -1.23, P = 0.016), HbA1C (WMD= -0.35, 95% CI: -0.55 to -0.15, P= 0.004), TNF-α (WMD = - 1.57, 95% CI: - 2.29 to - 0.85, P <0.05), IL-6 levels (WMD = - 1.15, 95% CI: -1.58 to - 0.72, P<0.001 and CRP (WMD = - 0.31, 95% CI: -0.47 to -0.16, P > 0.001) . No effect of ALA was detected in HOMA-IR and insulinConclusion: Alpha-lipoic acid treatment showed beneficial effects on some cardio- metabolicparameters. Further research is needed to examine the effect of different doses and the long-term benefits of ALA on the cardio-metabolic parameters

Alpha-Lipoic Acid, glycemic profile, chronic inflammation, cardiovascular disease, meta- analysis